US Food and Drug Administration Approval of Flibanserin: Even the Score Does Not Add Up

JAMA Intern Med. 2016 Apr;176(4):439-42. doi: 10.1001/jamainternmed.2016.0073.

Authors

Steven Woloshin¹, Lisa M Schwartz¹

Affiliation

¹ Center for Medicine and the Media, Dartmouth Institute for Health Policy and Clinical Practice, Lebanon, New Hampshire2Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire.

PMID: 26926770
DOI: 10.1001/jamainternmed.2016.0073

No abstract available

Publication types

Editorial

MeSH terms

Benzimidazoles / therapeutic use*
Clinical Trials, Phase III as Topic
Drug Approval*
Evidence-Based Medicine
Female
Humans
Patient Satisfaction
Sexual Dysfunctions, Psychological / drug therapy*
United States
United States Food and Drug Administration

Substances

Benzimidazoles
flibanserin